MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:DMED)

0.0450 -0.0050 (-10.00%)
Streaming Delayed Price Updated: 12:49 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 113,275
Open 0.0500
Bid (Size) 0.0400 (245,000)
Ask (Size) 0.0450 (15,000)
Prev. Close 0.0500
Today's Range 0.0450 - 0.0500
52wk Range 0.0300 - 0.2500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
DiagnaMed Completes Acquisition of Colchester East Natural Hydrogen Project in Nova Scotia
Toronto, Ontario--(Newsfile Corp. - May 15, 2026) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") announces... 
Via Newsfile
News headline image
DiagnaMed Enters Acquisition Agreement to Acquire Colchester East Natural Hydrogen Project in Nova Scotia
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is... 
Via Newsfile

Performance

YTD
-30.8%
-30.8%
1 Month
-10.0%
-10.0%
3 Month
-50.0%
-50.0%
6 Month
-25.0%
-25.0%
1 Year
+50.0%
+50.0%

More News

Read More
News headline image
DiagnaMed and QIMC Confirm Major Expansion of Hydrogen Zone by Over 11 Kilometers in Ontario's Temiscamingue Graben
Via Newsfile
Topics Artificial Intelligence
News headline image
DiagnaMed and QIMC Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Temiscamingue Graben
Via Newsfile
Topics Artificial Intelligence
News headline image
DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrogen Corridor
Via Newsfile
News headline image
DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben
Via Newsfile
Topics Climate Change
News headline image
DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program
Via Newsfile
News headline image
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Via Newsfile
News headline image
DiagnaMed Announces Chief Financial Officer Transition
Via Newsfile
News headline image
DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board
Via Newsfile
News headline image
DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben
Via Newsfile
News headline image
DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
From Revive Therapeutics Ltd.
Via GlobeNewswire
News headline image
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
Via Newsfile
News headline image
Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
From Revive Therapeutics Ltd.
Via GlobeNewswire
News headline image
DiagnaMed Announces LIFE Offering of up to $510,000
Via Newsfile
Topics Artificial Intelligence
News headline image
DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC
Via Newsfile
Topics Emissions
News headline image
DiagnaMed Advances Hydrogen Energy Technology Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed Announces Resignation of Director and Grant of Stock Options
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
News headline image
DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water
From DiagnaMed Holdings Corp.
Via GlobeNewswire

Frequently Asked Questions

Is DMED publicly traded?
Yes, DMED is publicly traded.
What exchange does DMED trade on?
DMED trades on the Canadian Securities Exchange
What is the ticker symbol for DMED?
The ticker symbol for DMED is DMED on the Canadian Securities Exchange
What is the current price of DMED?
The current price of DMED is 0.0450
When was DMED last traded?
The last trade of DMED was at 06/30/26 12:49 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story